Harnessing Nanogold in Therapeutic Cancer Vaccines

Abstract Cancer immunotherapy offers potential to harness one’s own immune system to eliminate existing cancer cells. Within this therapeutic umbrella, therapeutic cancer vaccines (TCVs) have been designed to train lymphocytes to recognize cancer cells as foreign invaders and eliminate them from the body. To enact this training, scientists have employed nanoscale gold constructs (nanogold) in varying ways throughout the cyclical process of antigen uptake, dendritic cell maturation, antigen presentation, T cell migration, and cancer cell elimination. In this review, we highlight the use of nanogold in TCVs, emphasizing the distinct properties that have been harnessed to improve diverse aspects of the TCV cycle. Ultimately, we discuss the challenges of utilizing nanogold in TCVs and provide our perspective on the direction of the field in upcoming years.

Authors

Publication Details

Journal
ACS Nano Medicine
Published
2026-11-14
DOI
https://doi.org/10.1021/acsnanomed.6c00228
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Harnessing Nanogold in Therapeutic Cancer Vaccines

Joshua Seaberg, Priyabrata Mukherjee, Resham Bhattacharya
ACS Nano Medicine
Immunotherapy and Immune Responses
article

Harnessing Nanogold in Therapeutic Cancer Vaccines

Joshua Seaberg, Priyabrata Mukherjee, Resham Bhattacharya
article en

Abstract

Abstract Cancer immunotherapy offers potential to harness one’s own immune system to eliminate existing cancer cells. Within this therapeutic umbrella, therapeutic cancer vaccines (TCVs) have been designed to train lymphocytes to recognize cancer cells as foreign invaders and eliminate them from the body. To enact this training, scientists have employed nanoscale gold constructs (nanogold) in varying ways throughout the cyclical process of antigen uptake, dendritic cell maturation, antigen presentation, T cell migration, and cancer cell elimination. In this review, we highlight the use of nanogold in TCVs, emphasizing the distinct properties that have been harnessed to improve diverse aspects of the TCV cycle. Ultimately, we discuss the challenges of utilizing nanogold in TCVs and provide our perspective on the direction of the field in upcoming years.

ACS Nano Medicine
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon